Home > Research > Publications & Outputs > Spatially Explicit Large-Scale Environmental Ri...

Electronic data

  • P1_Main_text_08_EST_R2_clean

    Rights statement: This document is the Accepted Manuscript version of a Published Work that appeared in final form in Environmental Science and Technology copyright © American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see https://pubs.acs.org/doi/10.1021/acs.est.8b07054

    Accepted author manuscript, 2.73 MB, PDF document

    Available under license: CC BY-NC: Creative Commons Attribution-NonCommercial 4.0 International License

Links

Text available via DOI:

View graph of relations

Spatially Explicit Large-Scale Environmental Risk Assessment of Pharmaceuticals in Surface Water in China

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Spatially Explicit Large-Scale Environmental Risk Assessment of Pharmaceuticals in Surface Water in China. / Zhu, Ying; Snape, Jason; Jones, Kevin et al.

In: Environmental Science and Technology, Vol. 53, No. 5, 21.02.2019, p. 2559-2569.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

APA

Vancouver

Zhu Y, Snape J, Jones K, Sweetman A. Spatially Explicit Large-Scale Environmental Risk Assessment of Pharmaceuticals in Surface Water in China. Environmental Science and Technology. 2019 Feb 21;53(5):2559-2569. Epub 2019 Feb 13. doi: 10.1021/acs.est.8b07054

Author

Zhu, Ying ; Snape, Jason ; Jones, Kevin et al. / Spatially Explicit Large-Scale Environmental Risk Assessment of Pharmaceuticals in Surface Water in China. In: Environmental Science and Technology. 2019 ; Vol. 53, No. 5. pp. 2559-2569.

Bibtex

@article{a92a235f7ea64e6bb48a459b60002611,
title = "Spatially Explicit Large-Scale Environmental Risk Assessment of Pharmaceuticals in Surface Water in China",
abstract = "With improving healthcare and an aging population, the consumption of human pharmaceuticals in China has been increasing dramatically. Environmental risks posed by many active pharmaceutical ingredients (APIs) are still unknown. This study used a spatially explicit dilution-factor methodology to model predicted environmental concentrations (PECs) of 11 human-use APIs in surface water for a preliminary environmental risk assessment (ERA). Median PECs in surface water across China range between 0.01 and 8.0 × 103 ng/L for the different APIs, under a moderate patient use scenario. Higher environmental risks of APIs in surface water are in regions with high water stress, e.g., northern China. Levonorgestrel, estradiol, ethinyl estradiol and abiraterone acetate were predicted to potentially pose a high or moderate environmental risk in China if consumption levels reach those in Europe. Relative risks of these four APIs have the potential to be among those chemicals with the highest impact on surface water in China when compared to the risks associated with other regulated chemicals, including triclosan and some standard water quality parameters including BOD5 (5-day biological oxygen demand), COD (chemical oxygen demand), Cu, Zn, and Hg and linear alkylbenzene sulfonate. This method could support the regulation of this category of chemicals and risk mitigation strategies in China.",
author = "Ying Zhu and Jason Snape and Kevin Jones and Andrew Sweetman",
note = "This document is the Accepted Manuscript version of a Published Work that appeared in final form in Environmental Science and Technology copyright {\textcopyright} American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see https://pubs.acs.org/doi/10.1021/acs.est.8b07054",
year = "2019",
month = feb,
day = "21",
doi = "10.1021/acs.est.8b07054",
language = "English",
volume = "53",
pages = "2559--2569",
journal = "Environmental Science and Technology",
issn = "0013-936X",
publisher = "American Chemical Society",
number = "5",

}

RIS

TY - JOUR

T1 - Spatially Explicit Large-Scale Environmental Risk Assessment of Pharmaceuticals in Surface Water in China

AU - Zhu, Ying

AU - Snape, Jason

AU - Jones, Kevin

AU - Sweetman, Andrew

N1 - This document is the Accepted Manuscript version of a Published Work that appeared in final form in Environmental Science and Technology copyright © American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see https://pubs.acs.org/doi/10.1021/acs.est.8b07054

PY - 2019/2/21

Y1 - 2019/2/21

N2 - With improving healthcare and an aging population, the consumption of human pharmaceuticals in China has been increasing dramatically. Environmental risks posed by many active pharmaceutical ingredients (APIs) are still unknown. This study used a spatially explicit dilution-factor methodology to model predicted environmental concentrations (PECs) of 11 human-use APIs in surface water for a preliminary environmental risk assessment (ERA). Median PECs in surface water across China range between 0.01 and 8.0 × 103 ng/L for the different APIs, under a moderate patient use scenario. Higher environmental risks of APIs in surface water are in regions with high water stress, e.g., northern China. Levonorgestrel, estradiol, ethinyl estradiol and abiraterone acetate were predicted to potentially pose a high or moderate environmental risk in China if consumption levels reach those in Europe. Relative risks of these four APIs have the potential to be among those chemicals with the highest impact on surface water in China when compared to the risks associated with other regulated chemicals, including triclosan and some standard water quality parameters including BOD5 (5-day biological oxygen demand), COD (chemical oxygen demand), Cu, Zn, and Hg and linear alkylbenzene sulfonate. This method could support the regulation of this category of chemicals and risk mitigation strategies in China.

AB - With improving healthcare and an aging population, the consumption of human pharmaceuticals in China has been increasing dramatically. Environmental risks posed by many active pharmaceutical ingredients (APIs) are still unknown. This study used a spatially explicit dilution-factor methodology to model predicted environmental concentrations (PECs) of 11 human-use APIs in surface water for a preliminary environmental risk assessment (ERA). Median PECs in surface water across China range between 0.01 and 8.0 × 103 ng/L for the different APIs, under a moderate patient use scenario. Higher environmental risks of APIs in surface water are in regions with high water stress, e.g., northern China. Levonorgestrel, estradiol, ethinyl estradiol and abiraterone acetate were predicted to potentially pose a high or moderate environmental risk in China if consumption levels reach those in Europe. Relative risks of these four APIs have the potential to be among those chemicals with the highest impact on surface water in China when compared to the risks associated with other regulated chemicals, including triclosan and some standard water quality parameters including BOD5 (5-day biological oxygen demand), COD (chemical oxygen demand), Cu, Zn, and Hg and linear alkylbenzene sulfonate. This method could support the regulation of this category of chemicals and risk mitigation strategies in China.

U2 - 10.1021/acs.est.8b07054

DO - 10.1021/acs.est.8b07054

M3 - Journal article

VL - 53

SP - 2559

EP - 2569

JO - Environmental Science and Technology

JF - Environmental Science and Technology

SN - 0013-936X

IS - 5

ER -